| Schedule of intangible assets |
Cost | | Licenses | | | Patents and drug approvals | | | Brand names and trademarks | | | Customer list | | | Software and technology | | | Total | | At December 31, 2023 | | $ | 1,227 | | | $ | 25,386 | | | $ | 4,746 | | | $ | 5,787 | | | $ | 1,031 | | | $ | 38,177 | | Additions | | | - | | | | 100 | | | | - | | | | - | | | | 639 | | | | 739 | | Transfer from prepaid expenses | | | - | | | | - | | | | - | | | | - | | | | 795 | | | | 795 | | Effect of movements in exchange rates | | | 107 | | | | 2,238 | | | | 417 | | | | 509 | | | | 147 | | | | 3,418 | | At December 31, 2024 | | $ | 1,334 | | | $ | 27,724 | | | $ | 5,163 | | | $ | 6,296 | | | $ | 2,612 | | | $ | 43,129 | | Additions - business combinations (note 4) | | | - | | | | - | | | | - | | | | 954 | | | | - | | | | 954 | | Effect of movements in exchange rates | | | (58 | ) | | | (1,316 | ) | | | (245 | ) | | | (305 | ) | | | (125 | ) | | | (2,049 | ) | At December 31, 2025 | | $ | 1,276 | | | $ | 26,408 | | | $ | 4,918 | | | $ | 6,945 | | | $ | 2,487 | | | $ | 42,034 | | | | | | | | | | | | | | | | | | | | | | | | | | | Accumulated amortization | | Licenses | | | Patents and drug approvals | | | Brand names and trademarks | | | Customer list | | | Software and technology | | | Total | | At December 31, 2023 | | $ | 532 | | | $ | 21,147 | | | $ | 4,388 | | | $ | 2,937 | | | $ | 233 | | | $ | 29,237 | | Amortization | | | 182 | | | | 620 | | | | 53 | | | | 746 | | | | 275 | | | | 1,876 | | Effect of movements in exchange rates | | | 56 | | | | 1,890 | | | | 389 | | | | 296 | | | | 31 | | | | 2,662 | | At December 31, 2024 | | $ | 770 | | | $ | 23,657 | | | $ | 4,830 | | | $ | 3,979 | | | $ | 539 | | | $ | 33,775 | | Amortization | | | 185 | | | | 633 | | | | 54 | | | | 845 | | | | 435 | | | | 2,152 | | Effect of movements in exchange rates | | | (40 | ) | | | (1,132 | ) | | | (230 | ) | | | (205 | ) | | | (34 | ) | | | (1,641 | ) | At December 31, 2025 | | $ | 915 | | | $ | 23,158 | | | $ | 4,654 | | | $ | 4,619 | | | $ | 940 | | | $ | 34,286 | | | | | | | | | | | | | | | | | | | | | | | | | | | Carrying amounts | | Licenses | | | Patents and drug approvals | | | Brand names and trademarks | | | Customer list | | | Software and technology | | | Total | | At December 31, 2024 | | $ | 564 | | | $ | 4,067 | | | $ | 333 | | | $ | 2,317 | | | $ | 2,073 | | | $ | 9,354 | | At December 31, 2025 | | $ | 361 | | | $ | 3,250 | | | $ | 264 | | | $ | 2,326 | | | $ | 1,547 | | | $ | 7,748 | |
|